Product image of Mometasonfuroaat Teva (Mometasone Furoate) supplied by GNH India

Mometasonfuroaat Teva

Active Ingredient:
Mometasone Furoate
Origin:
EU

Mometasonfuroaat Teva (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasonfuroaat Teva, is a corticosteroid presented as a nasal spray for endosinusial use. It is employed to manage inflammatory nasal conditions such as allergic rhinitis in both adults and children.

GNH India supplies Mometasonfuroaat Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Teva Nederland B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mometasone furoate nasal spray is used to treat inflammatory conditions of the nasal passages by reducing local immune response.

  • Allergic rhinitis: alleviates nasal congestion, itching, sneezing and rhinorrhea.
  • Nasal polyposis (post‑surgical): helps prevent recurrence of polyps after endoscopic sinus surgery.
  • Non‑allergic rhinitis: reduces nasal inflammation and improves airflow.

How It Works

  • Mometasone furoate binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This action suppresses the release of pro‑inflammatory cytokines, reduces vascular permeability, and inhibits leukocyte infiltration, resulting in localized anti‑inflammatory and immunosuppressive effects within the nasal mucosa.

Side Effects

Mometasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects

  • Nasal irritation or burning sensation.
  • Epistaxis (nosebleeds).
  • Headache.
  • Throat dryness.
  • Cough.
  • Unpleasant taste.

Serious or Rare Side Effects

  • Nasal septal perforation.
  • Secondary fungal or bacterial infections of the nasal cavity.
  • Elevated intra‑ocular pressure or glaucoma.
  • Adrenal suppression with prolonged high‑dose use.
  • Systemic corticosteroid effects such as hyperglycemia.

Precautions & Warnings

Before using Mometasone furoate nasal spray, consider the following safety measures.

  • Pregnancy: consult a healthcare professional; safety data are limited.
  • Breastfeeding: discuss potential risks with a physician.
  • Existing infections: avoid use if active nasal or sinus infections are present.
  • Surgery: discontinue prior to nasal or sinus surgery to reduce bleeding risk.
  • Long‑term use: monitor for signs of adrenal suppression or ocular pressure changes.
  • Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Mometasone furoate nasal spray can interact with other medications that affect corticosteroid metabolism or increase infection risk.

Major Interactions (Avoid)

  • Systemic CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) that may increase systemic exposure.
  • Live vaccines: concurrent use may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely)

  • Antifungal agents (e.g., fluconazole) that modestly raise corticosteroid levels.
  • Immunosuppressants (e.g., azathioprine) that may heighten infection risk.
  • Nasal decongestants: combined use may increase local irritation.
  • Other intranasal corticosteroids: avoid duplicate therapy to prevent excess exposure.

Frequently Asked Questions

Mometasonfuroaat Teva contains mometasone furoate, a corticosteroid indicated for the treatment of allergic rhinitis, prevention of nasal polyp recurrence after surgery, and relief of symptoms associated with non‑allergic rhinitis. It works locally in the nasal passages to reduce inflammation and improve breathing.

Mometasone furoate binds to glucocorticoid receptors inside nasal mucosal cells, altering gene expression to suppress inflammatory cytokines, reduce vascular leakage, and limit immune cell infiltration. This localized anti‑inflammatory action diminishes swelling, mucus production, and nasal congestion.

The prescribed dose of Mometasonfuroaat Teva is determined by the treating clinician based on the patient’s age, severity of symptoms, and specific indication. Patients should follow the dosing instructions provided on the prescription label and by their healthcare professional.

Safety data for mometasone furoate nasal spray in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Mometasone furoate is a high‑potency intranasal corticosteroid with a favorable safety profile due to minimal systemic absorption. Compared with agents such as fluticasone or budesonide, it offers comparable efficacy for allergic rhinitis while often requiring a lower daily dose, which may reduce the risk of systemic side effects.

Store the nasal spray at temperatures below 25 °C (77 °F) in its original packaging. Protect it from moisture, excessive heat and direct sunlight. Do not freeze the product, and keep the cap tightly closed when not in use.

Mometasonfuroaat Teva is administered as a nasal spray. The patient tilts the head slightly forward, inserts the nozzle into one nostril, and sprays the prescribed number of sprays while breathing in gently. The process is repeated in the other nostril if directed by the prescriber.

Serious risks, though rare, include nasal septal perforation, secondary fungal or bacterial infections of the nasal cavity, elevated intra‑ocular pressure leading to glaucoma, and systemic corticosteroid effects such as adrenal suppression when used at high doses for prolonged periods.

Patients with known hypersensitivity to mometasone furoate or any component of the formulation should avoid the product. It is also contraindicated in individuals with active untreated nasal or sinus infections, recent nasal surgery without physician clearance, or those who are using other intranasal corticosteroids without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mometasone Furoate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT